Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
暂无分享,去创建一个
E. Thiel | H. Stein | C. Loddenkemper | M. Zeitz | S. Miehlke | M. Bornhäuser | E. Berg | D. Wolff | L. Uharek | T. Schneider | K. Rieger | R. Duchmann | B. Steiner | T. Fietz | H. Terpe | J. Maul
[1] T. Giese,et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.
[2] A. Hanash,et al. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. , 2005, Blood.
[3] J. Glickman,et al. Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells. , 2004, Blood.
[4] T. Nomura,et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. , 2004, International immunology.
[5] C. Thoburn,et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. , 2004, Blood.
[6] J. Román-Gómez,et al. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft‐versus‐host disease after allogeneic bone marrow transplantation , 2004, British journal of haematology.
[7] C. Craddock,et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. , 2004, Blood.
[8] D. Couriel,et al. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. , 2004, Blood.
[9] J. Glickman,et al. Absence of Clinical GVHD and the In Vivo Induction of Regulatory T cells following Facilitating Cell Transplantation , 2004 .
[10] D. Klatzmann,et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. , 2003, The Journal of clinical investigation.
[11] C. Fathman,et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.
[12] Stephen C. Jones,et al. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[14] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[15] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[16] C. Baecher-Allan,et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.
[17] Bryon D Johnson,et al. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] C. Fathman,et al. Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.
[19] David Klatzmann,et al. CD4+CD25+ Immunoregulatory T Cells , 2002, The Journal of experimental medicine.
[20] A. Rudin,et al. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood , 2002, Immunology.
[21] H. Waldmann,et al. Both CD4+CD25+ and CD4+CD25− Regulatory Cells Mediate Dominant Transplantation Tolerance1 , 2002, The Journal of Immunology.
[22] B. Blazar,et al. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.
[23] P. Huie,et al. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. , 2002, Blood.
[24] M. Karim,et al. CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 , 2002, The Journal of Immunology.
[25] M. Horowitz,et al. A survey of diagnosis, management, and grading of chronic GVHD. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[27] E. Shevach. Certified Professionals , 2001, The Journal of experimental medicine.
[28] F. Powrie,et al. IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.
[29] E. Shevach,et al. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. , 1998, Journal of immunology.
[30] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[31] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[32] R. Herrmann,et al. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation. , 1995, Journal of clinical pathology.
[33] R. Lo,et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. , 1994, Gastroenterology.
[34] M. Zeitz,et al. Abnormalities in subset distribution, activation, and differentiation of T ceils isolated from large intestine biopsies in HIV infection , 1994 .
[35] M. Zeitz,et al. Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group. , 1994, Clinical and experimental immunology.
[36] S. Proctor,et al. IMMUNOPATHOLOGY OF EARLY GRAFT‐VERSUS-HOST DISEASE—A PROSPECTIVE STUDY OF SKIN, RECTUM, AND PERIPHERAL BLOOD IN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANT RECIPIENTS , 1991, Transplantation.
[37] J. Platt,et al. Inflammatory cells in graft-versus-host disease on the rectum: immunopathologic analysis. , 1991, Bone marrow transplantation.
[38] G. McDonald,et al. Gastrointestinal graft‐versus‐host disease in man: A clinicopathologic study of the rectal biopsy , 1979, The American journal of surgical pathology.